Clinical Trial Update: A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial (NCT06619613) evaluating CM383 in patients with Alzheimer's-related mild cognitive impairment and mild Alzheimer's disease is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• CM383

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Alzheimer Disease | Phase 1 | Status: RECRUITING